LOGGI, ELISABETTA
LOGGI, ELISABETTA
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Assegnisti
Diagnostic Performance of PIVKA-II in Italian Patients with Hepatocellular Carcinoma
2025 Guarneri, Valeria; Loggi, Elisabetta; Ramacieri, Giuseppe; Serra, Carla; Vukotic, Ranka; Vitale, Giovanni; Scuteri, Alessandra; Cursaro, Carmela; Margotti, Marzia; Galli, Silvia; Caracausi, Maria; Brodosi, Lucia; Gabrielli, Filippo; Andreone, Pietro
Proteomics of immune cells from liver tumors reveals immunotherapy targets
2023 Canale, Fernando P; Neumann, Julia; von Renesse, Janusz; Loggi, Elisabetta; Pecoraro, Matteo; Vogel, Ian; Zoppi, Giada; Antonini, Gaia; Wolf, Tobias; Jin, Wenjie; Zheng, Xiaoqin; La Barba, Giuliano; Birgin, Emrullah; Forkel, Marianne; Nilsson, Tobias; Marone, Romina; Mueller, Henrik; Pelletier, Nadege; Jeker, Lukas T; Civenni, Gianluca; Schlapbach, Christoph; Catapano, Carlo V; Seifert, Lena; Seifert, Adrian M; Gillessen, Silke; De Dosso, Sara; Cristaudi, Alessandra; Rahbari, Nuh N; Ercolani, Giorgio; Geiger, Roger
The function of specialized pro-resolving endogenous lipid mediators, vitamins, and other micronutrients in the control of the inflammatory processes: Possible role in patients with SARS-CoV-2 related infection
2022 Gallo C.G.; Fiorino S.; Posabella G.; Antonacci D.; Tropeano A.; Pausini E.; Pausini C.; Guarniero T.; Hong W.; Giampieri E.; Corazza I.; Loiacono R.; Loggi E.; de Biase D.; Zippi M.; Lari F.; Zancanaro M.
Virological Treatment Monitoring for Chronic Hepatitis B
2022 Loggi, Elisabetta; Gitto, Stefano; Gabrielli, Filippo; Franchi, Elena; Seferi, Hajrie; Cursaro, Carmela; Andreone, Pietro
SARS-CoV-2: lessons from both the history of medicine and from the biological behavior of other well-known viruses
2021 Fiorino, Sirio; Tateo, Fabio; Biase, Dario De; Gallo, Claudio G; Orlandi, Paolo E; Corazza, Ivan; Budriesi, Roberta; Micucci, Matteo; Visani, Michela; Loggi, Elisabetta; Hong, Wandong; Pica, Roberta; Lari, Federico; Zippi, Maddalena
Serum hepatitis B core-related antigen is an effective tool to categorize patients with HBeAg-negative chronic hepatitis B
2019 Loggi, Elisabetta; Vukotic, Ranka; Conti, Fabio; Grandini, Elena; Gitto, Stefano; Cursaro, Carmela; Galli, Silvia; Furlini, Giuliano; Re, Maria Carla; Andreone, Pietro*
Quality of life of hepatitis B virus surface antigen-positive patients with suppressed viral replication: comparison between inactive carriers and nucleot(s)ide analog-treated patients
2018 Simonetti, Giulia; Gitto, Stefano; Golfieri, Lucia; Gamal, Nesrine; Loggi, Elisabetta; Taruschio, Gianfranco; Cursaro, Carmela; Nunzella, Serena; Grandi, Silvana; Andreone, Pietro
Worsening of Serum Lipid Profile after Direct Acting Antiviral Treatment
2018 Gitto, Stefano; Cicero, Arrigo F G; Loggi, Elisabetta; Giovannini, Marina; Conti, Fabio; Grandini, Elena; Guarneri, Valeria; Scuteri, Alessandra; Vitale, Giovanni; Cursaro, Carmela; Borghi, Claudio; Andreone, Pietro
Hepatitis B virus reactivation among hepatitis C patients treated with direct-acting antiviral therapies in routine clinical practice
2017 Loggi, Elisabetta; Gitto, Stefano; Galli, Silvia; Minichiello, Mario; Conti, Fabio; Grandini, Elena; Scuteri, Alessandra; Vitale, Giovanni; Di Donato, Roberto; Cursaro, Carmela; Furlini, Giuliano; Andreone, Pietro*
METABOLIC EFFECTS OF ANTI-HCV DIRECT ACTING ANTIVIRALS (DAA): A RETROSPECTIVE STUDY
2017 Cicero, A; Gitto, S; Loggi, E; Giovannini, M; Conti, F; Grandini, E; Guarneri, V; Scuteri, A; Vitale, G; Cursaro, C; Borghi, C; Andreone, P
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies
2017 Velia C. Di Maio; Valeria Cento; Ilaria Lenci; Marianna Aragri; Piera Rossi; Silvia Barbaliscia; Michela Melis; Gabriella Verucchi; Carlo F. Magni; Elisabetta Teti; Ada Bertoli; Francesco Paolo Antonucci; Maria C. Bellocchi; Valeria Micheli; Chiara Masetti; Simona Landonio; Simona Francioso; Francesco Santopaolo; Adriano M. Pellicelli; Vincenza Calvaruso; Laura Gianserra; Massimo Siciliano; Dante Romagnoli; Raffaele Cozzolongo; Antonio Grieco; Jacopo Vecchiet; Filomena Morisco; Manuela Merli; Giuseppina Brancaccio; Antonio Di Biagio; Elisabetta Loggi; Claudio M. Mastroianni; Valeria Pace Palitti; Pierluigi Tarquini; Massimo Puoti; Gloria Taliani; Loredana Sarmati; Antonino Picciotto; Vincenzo Vullo; Nicola Caporaso; Maurizio Paoloni; Caterina Pasquazzi; Giuliano Rizzardini; Giustino Parruti; Antonio Craxì; Sergio Babudieri; Massimo Andreoni; Mario Angelico; Carlo F. Perno; Francesca Ceccherini-Silberstein; for the HCV Italian Resistance Network Study Group: [..; P. Andreone; E. Loggi; G. Verucchi; ..]
Vitamin E for the treatment of children with hepatitis B e antigen-positive chronic hepatitis: A systematic review and meta-analysis
2017 Fiorino, Sirio; Bacchi-Reggiani, Maria Letizia; Leandri, Paolo; Loggi, Elisabetta; Andreone, Pietro
Vitamin E for the treatment of E-antigen-positive chronic hepatitis B in paediatric patients: results of a randomized phase 2 controlled study.
2017 Fiorino, S; Loggi, E; Verucchi, G; Comparcola, D; Vukotic, R; Pavoni, M; Grandini, E; Cursaro, C; Maselli, S; Bacchi Reggiani, Ml; Puggioli, C; Badia, L; Galli, S; Viale, P; Bernardi, M; Andreone, P.
Liver grafts from hepatitis B surface antigen-positive donors: A review of the literature
2016 Loggi, Elisabetta; Conti, Fabio; Cucchetti, Alessandro; Ercolani, Giorgio; Pinna, ANTONIO DANIELE; Andreone, Pietro
Chronic hepatitis B: Are we close to a cure?
2015 Loggi, E; Giovanni, Vitale; Fabio, Conti; Mauro, Bernardi; Pietro, Andreone .
Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies
2015 Piluso, Alessia; Gragnani, Laura; Fognani, Elisa; Grandini, Elena; Monti, Monica; Stasi, Cristina; Loggi, Elisabetta; Margotti, Marzia; Conti, Fabio; Andreone, Pietro; Zignego, Anna Linda
Adaptive response in Hepatitis B virus infection
2014 Loggi E.; Gamal N.; Bihl F.; Bernardi M.; Andreone P.
Calcineurin inhibitors levels reduction during treatment with Sofosbuvir in liver transplanted patients.
2014 Vukotic R; Morelli M; Pinna AD; Margotti M; Foschi FG; Loggi E; Bernardi M; Andreone P.
The increase of Ribavirin dose improves sustained virological response in HCV-Genotype 1 patients with a partial response to PEG-Interferon and Ribavirin.
2014 Conti F; Vukotic R; Lorenzini S; Riili A; Cursaro C; Scuteri A; Loggi E; Galli S; Furlini G; Bernardi M; Andreone P.
Development of psychiatric symptoms during antiviral therapy for chronic hepatitis C: a retrospective study on 590 subjects.
2013 G. Simonetti, G. Vitale, G. Taruschio, C. Cursaro, A. Scuteri, L. Brodosi, F. Conti, E. Loggi, A.F. Cicero, M. Bernardi, P. Andreone